Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Learn About FDA Patient Engagement

Learn About FDA Patient Engagement

                        About the FDA Patient Representative Program
          When a Patient Speaks: Testimonials from FDA Patient Representatives
          How to Apply to the FDA Patient Representative Program
          FDA Patient Engagement Overview*
          FDA Patient Listening Sessions
          Patients Ask FDA
          Patients Matter Video Series
          Patient Engagement Collaborative
          Patient Engagement Cluster
          About the FDA and How You Can Get Involved


                        FDA Patient Engagement Opportunities Home
          For Patients
          Learn About FDA Patient Engagement
          About the FDA Patient Representative ProgramLearn About FDA Patient Engagement About the FDA Patient Representative Program
  
  	
    Share
    Post
    Linkedin

    Email
    PrintThe FDA Patient Representative Program® is the agency’s flagship program that offers patients and caregivers the opportunity to provide critical advice to the agency as it regulates medical products—drugs, biologics, and devices.

Role of the FDA Patient Representative®

The role of the FDA Patient Representative® is unique. Patients and advocates are appointed as Special Government Employees(temporary employees) to provide direct input to agency staff as they share valuable insight on their experiences with various diseases, conditions, and devices while gaining access to confidential information.  In some cases, Regular Government Employees are able to serve in this role. FDA Patient Representatives engage with scientific members and other experts as they participate on FDA Advisory Committees and panels and consult with agency’s review divisions.

An SGE is a special government employee. FDA appoints all advisory committee members (except the industry representative) as SGEs.

Candidates are carefully recruited and trained to prepare them for various agency-sponsored meetings and activities. It’s through this engagement that we learn of patient needs, priorities and preferences and gather meaningful data that informs medical product development and decision making.

The Program is managed by the Advisory Committee Oversight and Management Staff (ACOMS) within the Office of the Commissioner.

Recruitment

We recruit FDA Patient Representatives on an as-needed basis. Below are some areas of recruitment:

Recruitment Areas

autism
			metastatic breast cancerbeta-thalassemia major
			metastatic non-small cell lung cancerchild cerebral adrenoleukodystrophy
			metastatic small cell lung cancerchronic lymphocytic leukemia or indolent forms of non-Hodgkin lymphoma
			multidrug-resistant gram-negative infections including hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP)diffuse large B-cell lymphoma
			neuroblastomaepithelioid sarcoma
			ovarian cancerhemophilia
			triple-negative breast cancerHIV
			type I diabetes



Criteria for being considered as an FDA Patient Representative®

FDA selects FDA Patient Representatives® on various criteria. To be considered for the program, an applicant must be a legal U.S. citizen at least 18 years of age and have:

Personal experience with the disease either as a patient, or primary caregiver.
	Ability to be objective while representing the concerns of others in their communities.
	Willingness and ability to communicate in public their views  and perspectives.
	Knowledge about most treatment options and research for their areas of experience they are representing.
	Impartiality with minimal to no financial conflicts of interest or ethical issues for self or close family members (for example, financial interest, such as stock, in companies that may be affected by FDA decisions).Primary Activities for FDA Patient Representatives

Serve on FDA Advisory Committees and panels that are held to obtain independent expert advice on scientific, technical, and policy matters.
	Give us input earlier in the regulatory medical product development and review process by engaging directly with Division review staff.Conflicts of Interest

In order to serve as an FDA Patient Representative, candidates will be appointed as Special Government Employees (referred to as “SGEs”). Once appointed, FDA Patient Representatives must adhere to all federal government conflict-of-interest requirements and ethics guidelines. Prior to performing work for the Agency, all SGEs undergo conflict-of-interest screening. Agency staff will assist the SGE with the screening process.

For more information on this topic, view the presentation slides: Financial Conflicts of Interest Overview

Learn what experienced FDA Patient Representatives have to say about their role, the impact that it’s had on their lives, the lessons learned as they’ve served, and more. Watch our video series, “When a Patient Speaks: Testimonials from FDA Patient Representatives."

For more information about the FDA Patient Representative Program, check out our Frequently Asked Questions, or email us at FDAPatientRepProgram@fda.hhs.gov.

**FDA PATIENT REPRESENTATIVE PROGRAM** and **FDA PATIENT REPRESENTATIVE** are service marks of the US Department of Health and Human Services.

                                                                                  Content current as of:
      12/04/2023Learn About FDA Patient Engagement

          
                        About the FDA Patient Representative Program
          When a Patient Speaks: Testimonials from FDA Patient Representatives
          How to Apply to the FDA Patient Representative Program
          FDA Patient Engagement Overview*
          FDA Patient Listening Sessions
          Patients Ask FDA
          Patients Matter Video Series
          Patient Engagement Collaborative
          Patient Engagement Cluster
          About the FDA and How You Can Get Involved


                        FDA Patient Engagement Opportunities
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop